Cover Image
市場調查報告書

全球冠狀動脈支架市場 (裸機型、藥物釋放型、生物吸收性) :各市場區隔、各地區、各國

Global Coronary Stents Market (Bare Metal, Drug-Eluting, Bioresorable): Analysis By Segment, By Region, By Country 2016-2021

出版商 Azoth Analytics 商品編碼 405237
出版日期 內容資訊 英文 158 Pages
訂單完成後即時交付
價格
Back to Top
全球冠狀動脈支架市場 (裸機型、藥物釋放型、生物吸收性) :各市場區隔、各地區、各國 Global Coronary Stents Market (Bare Metal, Drug-Eluting, Bioresorable): Analysis By Segment, By Region, By Country 2016-2021
出版日期: 2016年11月30日 內容資訊: 英文 158 Pages
簡介

全球冠狀動脈支架市場,預計2016年∼2021年以3.05%的年複合成長率成長。

本報告提供全球冠狀動脈支架市場相關調查分析,各市場區隔的市場成果與預測,加上各國分析,市場動態,政策、規定形勢,主要企業等系統性資訊。

第1章 調查手法

第2章 摘要整理

第3章 策略性建議

第4章 全球冠狀動脈支架市場:分析

  • 產品概要
  • 全球冠狀動脈支架市場
  • 全球冠狀動脈支架市場:各市場區隔
  • 全球裸機型支架市場:各金額
  • 全球藥物釋放型支架市場:各金額
  • 全球生物可吸收支架市場:各市場區隔
  • 全球冠狀動脈支架市場:各地區
  • 冠狀動脈支架:開發平台分析

第5章 北美的冠狀動脈支架市場:分析

  • 北美的冠狀動脈支架市場:各金額
  • 北美的裸機型支架市場:各金額
  • 北美的藥物釋放型支架市場:各金額
  • 北美的生物可吸收支架市場:各金額
  • 北美的冠狀動脈支架市場:各國,比率
  • 北美的冠狀動脈支架市場:各國

第6章 歐洲的冠狀動脈支架市場:分析

  • 歐洲的冠狀動脈支架市場:各金額
  • 歐洲的裸機型支架市場:各金額
  • 歐洲的藥物釋放型支架市場:各金額
  • 歐洲的生物可吸收支架市場:各金額
  • 歐洲的冠狀動脈支架市場:各國,比率
  • 歐洲的冠狀動脈支架市場:各國

第7章 亞太地區的冠狀動脈支架市場:分析

  • 亞太地區的冠狀動脈支架市場:各金額
  • 亞太地區的裸機型支架市場:各金額
  • 亞太地區的藥物釋放型支架市場:各金額
  • 亞太地區的生物可吸收支架市場:各金額
  • 亞太地區的冠狀動脈支架市場:各國,比率
  • 亞太地區的冠狀動脈支架市場:各國

第8章 其他地區的冠狀動脈支架市場:分析

  • 其他地區的冠狀動脈支架市場:各金額
  • 其他地區的裸機型支架市場:各金額
  • 其他地區的藥物釋放型支架市場:各金額
  • 其他地區的生物可吸收支架市場:各金額
  • 其他地區的冠狀動脈支架市場:各國,比率
  • 其他地區的冠狀動脈支架市場:各國

第9章 市場動態

  • 趨勢
  • 推動因素
  • 課題

第10章 價格結構

第11章 政策、規定形勢

第12章 M&A,許可證的市場途徑

第13章 SWOT分析

第14章 五力分析模型

第15章 產品基準

第16章 企業簡介

  • Terumo Corporation
  • Boston Scientific
  • Stentys SA
  • MicroPort ScientificCorporation
  • Biotronik
  • Elixir Medical Corporation
  • Biosensors Inc.
  • Medtronic
  • Abbott Laboratories
  • 京都醫療設計
目錄

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research,the report aims to present the analysis of global coronary stent market on the basis of Segments (Bare Metal stents or BMS, Drug-Eluting Stents or DES and Bioresorbable Stents), By Region (North America, Europe, APAC and ROW)and By Country (USA, Canada,UK, Germany, India, Japan, China, Brazil, UAE).

Rising development of bioresorbable stents combined with the growing awareness towards cardiovascular risks in developing countries has resulted in the growth of coronary stents market. Cardiovascular diseases are witnessing growth on account of the rise in the lifestyle related diseases including obesity,diabetes, hypertension etc.

Among the types of coronary stents, market is expected to be driven by bioresorbable stents, mainly in the polylactic acid material. However, drug eluting stents will continue to generate major revenue while bare metal stents will further continue to decline.

While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure and rising focus on healthcare among the growing middle class population.

Global Coronary Stents Market is forecasted to grow at a CAGR of 3.05% during 2016 - 2021F, on account of rising incidences of cardiovascular diseases globally leading to growing number of stent procedures.

The North American region remains the major market followed by Europe in the actual period, while APAC and ROW will witness strong growth in the forecast period.

According to Azoth Analytics research report, Global Coronary Stents (Bare Metal,Drug-Eluting, Bioresorable) Market: Analysis By Segment, By Region, By Country(2016-2021) - (By Segment - Bare Metal stents (BMS), Drug-Eluting Stents (DES), Bioresorbable Stents; By Region - North America, Europe, APAC, ROW; By Country - USA, Canada, UK,Germany, India, Japan, China, Brazil, UAE), Global Coronary Stents market is projected to exhibit a CAGR of over ~3.05%during 2016 - 2021. On the basis of market segment, Global Coronary Stents Markethas been segmented as Bare Metal stents (BMS), Drug-ElutingStents (DES) and Bioresorbable Stents; analysed by Regions-North America, Europe, APAC, ROW and by Country - USA, Canada, UK,Germany, India, Japan, China, Brazil, UAE.

Scope of theReport

The report provides Segmentation by Stent Type:

  • Bare Metal stents
  • Drug-Eluting Stents
  • Bioresorbable Stents

The report provides coverage by Region:

  • North America
  • Europe
  • Asia Pacific
  • ROW

The report provides coverage by Country:

  • USA
  • Canada
  • UK
  • Germany
  • India
  • Japan
  • China
  • Brazil
  • UAE

Customization of the Report

The report could be customized according to the client's specific research requirements. No additional cost will be required to pay for limited additional research.

Table of Contents

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

  • 3.1. Bioresorbable Stents asthe Future Market
  • 3.2. Focus on Lowering of ASP in Coronary Stents
  • 3.3. Opportunities in APAC Region

4. Global Coronary Stents Market: An Analysis

  • 4.1. Product Overview
  • 4.2. Global Coronary Stents Market
    • 4.2.1. By Value (Historic 2011-15)
    • 4.2.2. By Value ( Forecast 2016E-2021F)
  • 4.3. Global Coronary Stent Market, By Segments
    • 4.3.1. In Percentage (2015)
    • 4.3.2. In Percentage (2021F)
  • 4.4. Global Bare Metal Stents, By Value
    • 4.4.1. By Value (Historic 2011-15)
    • 4.4.2. By Value (Forecast 2016E-2021F)
  • 4.5. Global Drug Eluting Stents, By Value
    • 4.5.1. By Value (Historic 2011-15)
    • 4.5.2. By Value ( Forecast 2016E-2021F)
  • 4.6. Global Bioresorbable Stents Market, By Segments
    • 4.6.1. By Value (Historic 2011-15)
    • 4.6.2. By Value ( Forecast 2016E-2021F)
  • 4.7. Global Coronary Stent Market, By Region
    • 4.7.1. In Percentage (2015)
    • 4.7.2. In Percentage (2021F)
  • 4.8. Coronary Stents:Pipeline Analysis

5. North America Coronary Stent Market: An Analysis

  • 5.1. North America Coronary Stent Market, By Value
    • 5.1.1. By Value (Historic 2011-15)
    • 5.1.2. By Value (Forecast 2016E-2021F)
  • 5.2. North America Bare Metal Stent Market , By Value
    • 5.2.1. By Value (Historic 2011-15)
    • 5.2.2. By Value ( Forecast 2016E-2021F)
  • 5.3. North America Drug Eluting Stent Market , By Value
    • 5.3.1. By Value (Historic 2011-15)
    • 5.3.2. By Value ( Forecast 2016E-2021F)
  • 5.4. North America Bioresorbable Stent Market , By Value
    • 5.4.1. By Value ( 2011-2021F)
  • 5.5. North America Coronary Stent Market, By Country , By Percentage
    • 5.5.1. In Percentage (2015)
    • 5.5.2. In Percentage (2021F)
  • 5.6. North America Coronary Stent Market, By Country (USA,Canada) (2011-2021F)
    • 5.6.1. USA Coronary Stents Market, By Value
      • 5.6.1.1. By Value (2011-2021F)
    • 5.6.2. Canada Coronary Stents Market, By Value
      • 5.6.2.1. By Value (2011-2021F)

6. Europe Coronary Stent Market: An Analysis

  • 6.1. Europe Coronary Stent Market , By Value
    • 6.1.1. By Value (Historic 2011-15)
    • 6.1.2. By Value ( Forecast 2016E-2021F)
  • 6.2. Europe Bare Metal Stent Market , By Value
    • 6.2.1. By Value (Historic 2011-15)
    • 6.2.2. By Value ( Forecast 2016E-2021F)
  • 6.3. Europe Drug Eluting Stent Market , By Value
    • 6.3.1. By Value (Historic 2011-15)
    • 6.3.2. By Value ( Forecast 2016E-2021F)
  • 6.4. Europe Bioresorbable Stent Market , By Value
    • 6.4.1. By Value (Historic 2012-15)
    • 6.4.2. By Value ( Forecast 2016E-2021F)
  • 6.5. Europe Coronary Stent Market, By Country , By Percentage
    • 6.5.1. In Percentage (2015)
    • 6.5.2. In Percentage (2021F)
  • 6.6. Europe Coronary Stent Market, By Country (UK,Germany(2011-2021F)
    • 6.6.1. UK Coronary Stents Market, By Value
      • 6.6.1.1. By Value (2011-2021F)
    • 6.6.2. Germany Coronary Stents Market, By Value
      • 6.6.2.1. By Value (2011-2021F)

7. APAC Coronary Stent Market: An Analysis

  • 7.1. APAC Coronary Stent Market , By Value
    • 7.1.1. By Value (Historic 2011-15)
    • 7.1.2. By Value ( Forecast 2016E-2021F)
  • 7.2. APAC Bare Metal Stent Market , By Value
    • 7.2.1. By Value (Historic 2011-15)
    • 7.2.2. By Value ( Forecast 2016E-2021F)
  • 7.3. APAC Drug Eluting Stent Market , By Value
    • 7.3.1. By Value (Historic 2011-15)
    • 7.3.2. By Value ( Forecast 2016E-2021F)
  • 7.4. APAC Bioresorbable Stent Market , By Value
    • 7.4.1. By Value ( Forecast 2011-2021F)
  • 7.5. APAC Coronary Stent Market, By Country , By Percentage
    • 7.5.1. In Percentage (2015)
    • 7.5.2. In Percentage (2021F)
  • 7.6. APAC Coronary Stent Market, By Country (China, Japan , India) (2011-2021F)
    • 7.6.1. China Coronary Stents Market, By Value
      • 7.6.1.1. By Value (2011-2021F)
    • 7.6.2. Japan Coronary Stents Market, By Value
      • 7.6.2.1. By Value (2011-2021F)
    • 7.6.3. India Coronary Stents Market, By Value
      • 7.6.3.1. By Value (2011-2021F)

8. ROW Coronary Stent Market: An Analysis

  • 8.1. ROW Coronary Stent Market , By Value
    • 8.1.1. By Value (Historic 2011-15)
    • 8.1.2. By Value ( Forecast 2016E-2021F)
  • 8.2. ROW Bare Metal Stent Market , By Value
    • 8.2.1. By Value (Historic 2011-15)
    • 8.2.2. By Value ( Forecast 2016E-2021F)
  • 8.3. ROW Drug Eluting Stent Market , By Value
    • 8.3.1. By Value (Historic 2011-15)
    • 8.3.2. By Value ( Forecast 2016E-2021F)
  • 8.4. ROW Bioresorbable Stent Market , By Value
    • 8.4.1. By Value ( Forecast 2012-2021F)
  • 8.5. ROW Coronary Stent Market, By Country , By Percentage
    • 8.5.1. In Percentage (2015)
    • 8.5.2. In Percentage (2021F)
  • 8.6. ROW Coronary Stent Market, By Country (Brazil, UAE) (2011-2021F)
    • 8.6.1. Brazil Coronary Stents Market, By Value
      • 8.6.1.1. By Value (2011-2021F)
    • 8.6.2. UAE Coronary Stents Market, By Value
      • 8.6.2.1. By Value (2011-2021F)

9. Market Dynamics

  • 9.1. Trends
  • 9.2. Drivers
  • 9.3. Challenges

10. Pricing Structure

11. Policy and Regulatory Landscape

12. M&A and Licensing Route to Coronary Stent Market

13. SWOT Analysis

14. Porter's Five Forces Model

15. Product Benchmarking

16. Company Profiling

  • 16.1. Terumo Corporation
  • 16.2. Boston Scientific
  • 16.3. Stentys SA
  • 16.4. MicroPort ScientificCorporation
  • 16.5. Biotronik
  • 16.6. Elixir Medical Corporation
  • 16.7. Biosensors Inc.
  • 16.8. Medtronic
  • 16.9. Abbott Laboratories
  • 16.10. Kyoto Medical Planning

List of Figures

  • Figure 1: Global Coronary Stent Market Size, By Value, 2011-2021F (USD Billion)
  • Figure 2: Number of Annual Deaths Due to Cardiovascular Diseases
  • Figure 3: Life and Non Life Insurance Penetration in Select Countries 2015 in Percentage
  • Figure 4: Global Coronary Stent Market Segment Share 2015 In Percentage
  • Figure 5: Global Coronary Stent Market Segment Share 2021 In Percentage
  • Figure 6: Global Bare Metal Stent Market, By Value ,Historic(2011-2015) in USD Billion
  • Figure 7: Global Bare Metal Stent Market, By Value ,Forecast(2016E-2021F) in USD Billion
  • Figure 8: Global Drug Eluting Stent Market, By Value ,Historic(2011-2015) in USD Billion
  • Figure 9: Global Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Billion
  • Figure 10: Global Bioresorbable Stent Market, By Value ,Historic(2011-2015) in USD Million
  • Figure 11: Global Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million
  • Figure 12: Global Coronary Stent Market Region Share 2015 In Percentage
  • Figure 13: Global Coronary Stent Market Region Share 2021 In Percentage
  • Figure 14: North America Coronary Stent Market, By Value , Historic(2011-2015) in USD Billion
  • Figure 15: North America Coronary Stent Market By Value , Forecast (2016E-2021F) in USD Billion
  • Figure 16: Payment for Cardiology Services in USA
  • Figure 17: North America Bare Metal Stent Market, By Value , Historic(2011-2015) in USD Million
  • Figure 18: North America Bare Metal Stent Market By Value , Forecast(2016E-2021F) in USD Million
  • Figure 19: North America Drug Eluting Stent Market, By Value ,Historic(2011-2015) in USD Billion
  • Figure 20: North America Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Billion
  • Figure 21: North America Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million
  • Figure 22: North America Coronary Stent Market, By Country - 2015(%)
  • Figure 23: North America Coronary Stent Market, By Country - 2021F(%)
  • Figure 24: USA Coronary Stent Market, By Value , Historic(2011-2015) in USD Billion
  • Figure 25: USA Coronary Stent Market By Value , Forecast(2016E-2021F)in USD Billion
  • Figure 26: Percentage of Population Suffering From Cardiovascular Disease in USA (2009-2012)
  • Figure 27: Direct and Indirect Costs Associated With Major Heart Diseases in USA (USD Billion)(2009-2012)
  • Figure 28: Canada Coronary Stent Market, By Value , Historic(2011-2015) in USD Million
  • Figure 29: Canada Coronary Stent Market By Value ,Forecast (2016E-2021F) in USD Million
  • Figure 30: Europe Coronary Stent Market, By Value , Historic(2011-2015) in USD Billion
  • Figure 31: Europe Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Billion
  • Figure 32: Cost of CVD in 2014 in some European Countries
  • Figure 33: Europe Bare Metal Stent Market, By Value ,Historic(2011-2015) in USD Million
  • Figure 34: Europe Bare Metal Stent Market, By Value ,Forecast(2016E-2021F) in USD Million
  • Figure 35: Europe Drug Eluting Stent Market, By Value ,Historic(2011-2015) in USD Billion
  • Figure 36: Europe Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Billion
  • Figure 37: Europe Bioresorbable Stent Market, By Value ,Historic(2011-2015) in USD Million
  • Figure 38: Europe Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USDMillion
  • Figure 39: Europe Coronary Stent Market, By Country - 2015(%)
  • Figure 40: Europe Coronary Stent Market, By Country - 2021F(%)
  • Figure 41: UK Coronary Stent Market, By Value ,Historic(2011-2015) in USD Million
  • Figure 42: UK Coronary Stent Market By Value , Forecast(2016E-2021F)in USD Million
  • Figure 43: Germany Coronary Stents Market, By Value ,Historic(2011-2015) in USD Million
  • Figure 44: Germany Coronary Stents Market By Value ,Forecast(2016E-2021F) in USD Million
  • Figure 45: Others Coronary Stent Market, By Value , Historic(2011-2015) in USD Million
  • Figure 46: Others Coronary Stent Market By Value ,Forecast (2016E-2021F) in USD Million
  • Figure 47: APAC Coronary Stent Market, By Value ,Historic(2011-2015) in USD Billion
  • Figure 48: APAC Coronary Stent Market By Value ,Forecast (2016E-2021F) in USD Billion
  • Figure 49: APAC Bare Metal Stent Market, By Value ,Historic(2011-2015) in USD Million
  • Figure 50: APAC Bare Metal Stent Market, By Value ,Forecast (2016E-2021F) in USD Million
  • Figure 51: APAC Drug Eluting Stent Market, By Value , Historic(2011-2015) in USDMillion
  • Figure 52: APAC Drug Eluting Stent Market By Value , Forecast (2016E-2021F) in USD Million
  • Figure 53: APAC Bioresorbable Stent Market, By Value , Historic(2011-2015)in USD Million
  • Figure 54: APAC Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USDMillion
  • Figure 55: APAC Coronary Stent Market, By Country - 2015(%)
  • Figure 56: APAC Coronary Stent Market, By Country - 2021F(%)
  • Figure 57: China Coronary Stent Market, By Value ,Historic(2011-2015) in USD Million
  • Figure 58: China Coronary Stent Market By Value ,Forecast(2016E-2021F) in USD Million
  • Figure 59: Japan Coronary Stent Market, By Value ,Historic(2011-2015) in USD Million
  • Figure 60: Japan Coronary Market By Value , Forecast(2016E-2021F)in USD Million
  • Figure 61: India Coronary Stent Market, By Value , Historic(2011-2015) in USD Million
  • Figure 62: India Coronary Stent Market By Value ,Forecast(2016E-2021F) in USD Million
  • Figure 63: ROW Coronary Stent Market, By Value ,Historic(2011-2015) in USD Million
  • Figure 64: ROW Coronary Stent Market By Value , Forecast(2016E-2021F)in USD Million
  • Figure 65: ROW Coronary Stent Market, By Value , Historic(2011-2015) in USD Million
  • Figure 66: ROW Coronary Stent Market By Value , Forecast(2016E-2021F)in USD Million
  • Figure 67: ROW Bare Metal Stent Market, By Value ,Historic(2011-2015) in USD Million
  • Figure 68: ROW Bare Metal Stent Market, By Value ,Forecast(2016E-2021F) in USD Million
  • Figure 69: ROW Drug Eluting Stent Market, By Value ,Historic(2011-2015) in USD Billion
  • Figure 70: ROW Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USDBillion
  • Figure 71: ROW Bioresorbable Stent Market, By Value ,Historic(2011-2015) in USD Million
  • Figure 72: ROW Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million
  • Figure 73: ROW Coronary Stent Market, By Country - 2015(%)
  • Figure 74: ROW Coronary Stent Market, By Country - 2021F(%)
  • Figure 75: Brazil Coronary Stent Market, By Value , Historic(2011-2015) in USD Million
  • Figure 76: Brazil Coronary Stent Market By Value ,Forecast(2016E-2021F) in USD Million
  • Figure 77: UAE Coronary Stent Market, By Value , Historic(2011-2015) in USD Million
  • Figure 78: UAE Coronary Stent Market By Value , Forecast(2016E-2021F)in USD Million
  • Figure 79: Causes of Death in UAE
  • Figure 80: Others Coronary Stent Market, By Value , Historic(2011-2015) in USD Million
  • Figure 81: Others Coronary Stent Market By Value ,Forecast(2016E-2021F) in USD Million
  • Figure 82: Average Price of Bare-metal stents
  • Figure 83: Average Price of Drug Eluting stents
  • Figure 84: Cardiac And Vascular Business, By Segment-2015
  • Figure 85: Cardiac And Vascular Business, By Geography - 2015
  • Figure 86: Revenue, By Segment-2015 (in Percentage)
  • Figure 87: Revenue, By Geography - 2015
  • Figure 88: Revenue, By Segment-2015 (in Percentage)
  • Figure 89: Revenue, By Geography - 2015
  • Figure 90: Revenue, By Segment-2015(in Percentage)
  • Figure 91: Cardiac and Vascular Group Revenue, By Geography - 2015
  • Figure 92: Revenue, By Segment-2015 (in Percentage)
  • Figure 93: Overall Revenue,By Geography - 2015

List of Tables

  • Table 1: Number of Physicians in Cardiology in Canada in 2016
  • Table 2: Average Price of Bare-metal stents
  • Table 3: Average Price of Drug Eluting stents
  • Table 4: Cardio and Vascular Business Revenue By Segment (in USD Billion)
Back to Top